D

DongBang Medical Co Ltd
KOSDAQ:240550

Watchlist Manager
DongBang Medical Co Ltd
KOSDAQ:240550
Watchlist
Price: 6 480 KRW 2.86% Market Closed
Market Cap: ₩135.6B

Intrinsic Value

The intrinsic value for DongBang Medical Co Ltd (240550) under the Base Case is 10 306.34 KRW. Compared with the current market price of 6 480 KRW, the stock appears Undervalued by 37%.

Intrinsic Value
Base Case
10 306.34 KRW
Undervaluation 37%
Intrinsic Value
Price ₩6 480
D
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value ₩8 245.07
Get notified when the price drops into your buy zone
Intrinsic Value ₩10 306.34
Margin of Safety 20% ₩8 245.07
Current Price ₩6 480
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about DongBang Medical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DongBang Medical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for DongBang Medical Co Ltd.

Explain Valuation
Alternatives to DongBang Medical Co Ltd

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
DongBang Medical Co Ltd

Efficiency

Earnings Waterfall
DongBang Medical Co Ltd

Wall St
Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one DongBang Medical Co Ltd stock?

The intrinsic value for DongBang Medical Co Ltd (240550) under the Base Case is 10 306.34 KRW.

Is DongBang Medical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 6 480 KRW, the stock appears Undervalued by 37%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett